Search Results - "Whitley, C. B."
-
1
Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome
Published in Bone marrow transplantation (Basingstoke) (01-03-2008)“…Hurler syndrome (mucopolysaccharidosis type I, MPS IH) is characterized by a deficiency of α- L -iduronidase resulting in progressive multiorgan dysfunction…”
Get full text
Journal Article -
2
Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation
Published in Bone marrow transplantation (Basingstoke) (01-06-2008)“…Short stature is characteristic of Hurler syndrome, or mucopolysaccharidosis type IH (MPS IH). Hematopoietic stem cell transplantation (HSCT) is used to treat…”
Get full text
Journal Article -
3
Increased longevity and metabolic correction following syngeneic BMT in a murine model of mucopolysaccharidosis type I
Published in Bone marrow transplantation (Basingstoke) (01-09-2012)“…Mucopolysaccharidosis type I (MPS I) is an autosomal recessive inherited disease caused by deficiency of the glycosidase α- L -iduronidase (IDUA). Deficiency…”
Get full text
Journal Article -
4
SAAMP 2.0: An algorithm to predict genotype‐phenotype correlation of lysosomal storage diseases
Published in Clinical genetics (01-05-2018)“…Lysosomal storage diseases (LSDs) are a group of genetic disorders, resulting from deficiencies of lysosomal enzyme. Genotype‐phenotype correlation is…”
Get full text
Journal Article -
5
The nature and impact of neurobehavioral symptoms in neuronopathic Hunter syndrome
Published in Molecular genetics and metabolism reports (01-03-2020)“…In neuronopathic Hunter syndrome, neurobehavioral symptoms are known to be serious but have been incompletely described. While families face significant stress…”
Get full text
Journal Article -
6
Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I
Published in Gene therapy (01-11-2000)“…To optimize a gene transfer system for hematopoietic stem cell gene therapy of patients with mucopolysaccharidosis (MPS) type I, 10 retroviral vectors were…”
Get full text
Journal Article -
7
Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion
Published in Clinical chemistry (Baltimore, Md.) (01-03-1989)“…This direct method for quantifying excessive urinary glycosaminoglycan excretion exploits the specific binding of 1,9-dimethylmethylene blue (DMB). The…”
Get more information
Journal Article -
8
Real-time quantitative polymerase chain reaction to assess gene transfer
Published in Human gene therapy (10-10-1999)“…Accurate quantification of gene transfer (or gene correction) is a universal challenge in the field of gene therapy. In developing a clinical trial of…”
Get more information
Journal Article -
9
Response to: Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome
Published in Molecular genetics and metabolism reports (01-03-2020)Get full text
Journal Article -
10
A new mtDNA mutation in the tRNA(Leu(UUR)) gene associated with maternally inherited cardiomyopathy
Published in Human mutation (1994)“…We report a new mutation, a C to T transition at nt 3303 of mtDNA, in seven members of a family with cardiomyopathy and myopathy: the proband and two siblings…”
Get more information
Journal Article -
11
Molecular genetic defect underlying α-L-iduronidase pseudodeficiency
Published in American journal of human genetics (1996)“…Mucopolysaccharidosis type I (i.e., Hurler, Hurler-Scheie, and Scheie syndromes) and type II (i.e., Hunter syndrome) are lysosomal storage disorders resulting…”
Get full text
Journal Article -
12
Genotype-Phenotype Correspondence in Sanfilippo Syndrome Type B
Published in American journal of human genetics (01-01-1998)“…Sanfilippo syndrome type B, or mucopolysaccharidosis type IIIB, results from defects in the gene for α-N-acetylglucosaminidase (NAGLU); only a few mutations…”
Get full text
Journal Article -
13
NAGLU Mutations Underlying Sanfilippo Syndrome Type B
Published in American journal of human genetics (01-01-1998)“…Sanfilippo syndrome type B (mucopolysaccharidosis III B) is a rare autosomal recessive disease caused by deficiency of α-N-acetylglucosaminidase, one of the…”
Get full text
Journal Article -
14
Busulfan Disposition in Children
Published in Blood (15-04-1990)“…Children receive busulfan orally as part of myeloablative therapy before bone marrow transplantation for malignant and nonmalignant conditions. Children have…”
Get full text
Journal Article -
15
Metabolic Correction and Cross-Correction of Mucopolysaccharidosis Type II (Hunter Syndrome) by Retroviral-Mediated Gene Transfer and Expression of Human Iduronate-2-Sulfatase
Published in Proceedings of the National Academy of Sciences - PNAS (15-12-1993)“…To explore the possibility of using gene transfer to provide iduronate-2-sulfatase (IDS; EC 3.1.6.13) enzyme activity for treatment of Hunter syndrome, an…”
Get full text
Journal Article -
16
Combined ultrafiltration-transduction in a hollow-fiber bioreactor facilitates retrovirus-mediated gene transfer into peripheral blood lymphocytes from patients with mucopolysaccharidosis type II
Published in Human gene therapy (20-11-1999)“…The process of growing and transducing large quantities of human primary peripheral blood lymphocytes (PBLs) with high gene transfer efficiency continues to be…”
Get more information
Journal Article -
17
Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome
Published in Transfusion (Philadelphia, Pa.) (01-04-1999)“…BACKGROUND: Gene therapy using autologous peripheral blood lymphocytes (PBLs) has been used to produce adenosine deaminase with which to treat patients with…”
Get full text
Journal Article -
18
Enzymatic correction and cross-correction of mucopolysaccharidosis type I fibroblasts by adeno-associated virus-mediated transduction of the alpha-L-iduronidase gene
Published in Human gene therapy (01-09-1999)“…Mucopolysaccharidosis type I (MPS I), a deficiency in the lysosomal enzyme alpha-L-iduronidase (IDUA), is characterized by skeletal abnormalities,…”
Get more information
Journal Article -
19
Retroviral transduction of peripheral blood leukocytes in a hollow- fiber bioreactor
Published in Transfusion (Philadelphia, Pa.) (01-07-1997)“…BACKGROUND: Peripheral blood white cells (leukocytes) (PBLs) have been used as effective targets for genetic manipulation by transduction with retroviruses in…”
Get full text
Journal Article -
20
Pathology of the liver in mucopolysaccharidosis: light and electron microscopic assessment before and after bone marrow transplantation
Published in Bone marrow transplantation (Basingstoke) (01-09-1992)“…Serial liver biopsies were obtained in 20 patients undergoing bone marrow transplantation (BMT) for mucopolysaccharidosis (MPS). The 13 patients with MPS I,…”
Get more information
Journal Article